Jpmorgan Chase & Co »

Intensity Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Intensity Therapeutics (INTS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Intensity Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intensity Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intensity Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-09-30 $64 17 3.82
2024-06-30 $88 18 4.89
2024-03-31 $46k 8.9k 5.20
2023-12-31 $343 40 8.58
2023-09-30 $4 1 4.00